Arkolith/Insider Trading/IBIO/Form 4

Isett Thomas Francis 3rd

CEO and Executive Chairman, DirectoriBio, Inc. (IBIO) · full profile →Form 4 · filed Sep 12, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
0 non-derivative · 1 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 8, 2022Grant(A)2.0M—$02.0M

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-099236) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML